Brought to you by
ECR 2019 / C-0221
Certificate of Merit
Adverse events of Targeted Anticancer Therapies: what the radiologist should know.
Congress: ECR 2019
Poster No.: C-0221
Type: Educational Exhibit
Keywords: Drugs / Reactions, Cancer, Biological effects, Treatment effects, Diagnostic procedure, CT, Thorax, Oncology, Abdomen
Authors: P. Lopez Sala, N. Alberdi, L. A. De Llano Ibisate, G. Unzue, C. Saavedra Gutierrez, N. Alonso Ordás, G. Rodriguez Henao, T. Lage Vidal, S. Gonzalez Iban; Pamplona/ES


Understanding molecular mechanisms of TAT and recognizing their AE is essential to guide appropriate treatment and avoid potential imaging pitfalls that could be mistaken for cancer progression. As our knowledge about molecular biology increases, so will drugs and their AE. A close communication between the oncologist and radiologist is indispensable in our day-to-day work.

POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more